Sander Fortanier

Sander Fortanier is a seasoned professional in the field of clinical research and development, currently serving as Clinical Program Director at CSL Seqirus since June 2017. Prior to this role, Sander held positions as Principal Clinical Scientist and Senior Clinical Scientist within the same organization. Sander's extensive experience includes a PhD fellowship at UMC Utrecht and a role as Research Project Lead at The Janssen Pharmaceutical Companies of Johnson & Johnson, focusing on bacterial vaccines. Previous roles at GlaxoSmithKline and AstraZeneca provided Sander with a solid foundation in medical advisory and clinical research. Sander's educational background includes a PhD in Epidemiology from Utrecht University and a Master of Science from Vrije Universiteit Amsterdam, along with a degree in Physical Therapy from Hogeschool West-Brabant.